Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

1 in 3 pets are homeless according to new global report – research shines a light on challenges facing pets today

Published

on

1-in-3-pets-are-homeless-according-to-new-global-report-–-research-shines-a-light-on-challenges-facing-pets-today
  • New research shows the global scale of pet homelessness estimating there are almost 362 million homeless cats and dogs across 20 countries studied.
  • Project launched by global coalition of leading animal welfare experts in partnership with Mars, with the shared ambition to end pet homelessness.
  • Mars Petcare Global President Loïc Moutault says that while pets are more popular than ever, there are a huge number of companion animals in need of care.

MCLEAN, Va., Jan. 23, 2024 /PRNewswire/ — Today, a global coalition of animal welfare experts in partnership with Mars, released the results from the largest ever international study into pet homelessness. ‘The State of Pet Homelessness Project’ set out to understand the scale of pet homelessness and factors that contribute to pets being on the streets or in shelters, shining a light on the needs of a huge hidden population of pets today.

The ambition of the project is to drive more informed and targeted action to help reduce homelessness and ensure pets get the care they need. The findings from the countries revealed a stark picture that almost 35% of cats and dogs are either living on the streets or currently in a shelter waiting to find a home. Across the 20 markets there are:

  • 143 million dogs living on the street and 12 million dogs in shelters,
  • 203 million cats living on the street and 4 million cats in shelters.

Jeffrey Flocken, President, Humane Society International said: “Dog and cat homelessness is a hugely complex issue, this new data will help animal welfare organizations, policymakers, pet professionals, academics and researchers to better understand the scale and factors influencing the issue, which can in turn support the most impactful interventions.”

The ‘State of Pet Homelessness Project’ used data from over 900 global and local sources, along with almost 30,000 public surveys and 200 expert interviews to build a picture of pet homelessness across: Australia, Brazil, Canada, China, France, Germany, Greece, India, Indonesia, Japan, Lithuania, Mexico, New Zealand, The Philippines, Poland, South Africa, Turkey, Thailand, the USA, and  the UK.

While each country has different challenges, the data also reveals several common themes across the twenty countries:

  • Pet–friendly housing limitations: Almost 1 in 5 people that are considering giving up their cat or dog in the near future say it’s because they are moving home and cannot take their pet with them. And almost half of those who have rehomed a pet in the past did so for that reason.
  • Pet ownership challenges: Globally around 15% of pet owners are considering giving up their pet in the next 12 months.
    • A number of factors contribute, with personal health and fitness challenges to still be able to care for a pet being the number one reason globally, housing related factors coming second, and time pressure to be able to look after a pet being the third most common reason. Other factors like behaviour, family allergies and cost also appear in the data.
  • Stemming homeless population increase:
    • A surprising number of people lose their pet, and often don’t get reunited. Almost half of people surveyed said they had lost a pet in the past, and of those almost 60% were never found by their owners.
    • Globally, pet owners report that only ~50% of owned dogs and ~60% of cats are sterilized, meaning the remainder, if allowed to reproduce unchecked, can result in unplanned litters, exacerbating the problem.

Loïc Moutault, Global President Mars Petcare said: “We know that pets bring enormous benefit to our lives, we want to help ensure all pets get the care they need. For every two dogs or cats that are part of a family or community in the countries surveyed, there is another that is not so fortunate. That is not the world we want for pets, and we hope this data will help drive targeted interventions to give more pets the life they deserve.

Big and small actions can make a difference, from considering adopting a pet, to changes that mean more rental accommodation allows pets helping to keep pets and pet owners together. We are setting out to support 30million vulnerable pets over the next five years and hope this data will allow us – and others – to make interventions that make a big difference.”

Working alongside Mars on this global data initiative is an advisory panel of leading animal welfare experts from organizations, including: Humane Society International, Alliance for Contraception in Cats & Dogs, International Partnership for Dogs and the International Companion Animal Management Coalition.

To mark the release of this data, Mars has made a $500,000 donation to Humane Society International to fund projects in India, South Africa and Mexico to make interventions informed by the data. These programs will deliver reproduction control, training and care for thousands of animals. This builds on a significant history of work by Mars and its partners supporting almost 10 million vulnerable pets across the world over the last three years. Including donating more than 100 million meals to vulnerable pets, steralizing over 30 thousand free-roaming animals and providing over 100,000 pets with comprehensive preventive care, including wellness checks, preventive medicine and vaccinations.

To find out more about the State of Pet Homelessness Project and to go deeper in to the data visit: www.stateofpethomelessness.com

 

About the State of Pet Homelessness Project
The ‘State of Pet Homelessness Project’ reviewed  data from over 900 global and local sources, along with 30,000 public surveys and 200 expert interviews: to shine a light on the needs of pets in the Australia, Brazil, Canada, China, France, Germany, Greece, India, Indonesia, Japan, Lithuania, Mexico, New Zealand, The Philippines, Poland, South Africa, Turkey, Thailand, the USA, and  the UK. It follows on from a pilot research study carried out in 2021 that looked at nine countries.

Data collection was carried out by specialist research agencies, Kantar and Euromonitor International. Data collection and analysis took from late 2022 and the first half of 2023.

Global Advisory Panel: The State of Pet Homelessness Project Advisory Panel is made up of Mars partners, and leaders in the animal welfare and pet care industry, including: Jeffrey Flocken (President, Humane Society International), Joyce Briggs (Senior Advisor and former President, Alliance for Contraception in Cats & Dogs), Andrew Rowan (President, WellBeing International), Marc Ralsky (CEO, International Partnership for Dogs), Vicky Halls (Head of Unowned Cats, International Cat Care), Brenda N. Bonnett (former CEO, International Partnership for Dogs), Claire Bessant (former Chief Executive, International Cat Care), Elly Hiby (Director, The International Companion Animal Management (ICAM) Coalition), Ellen Jefferson (President and CEO, Austin and American Pets Alive!), Kim Van Syoc (Executive Director, Banfield Foundation and VCA Charities)

About Mars, Incorporated
Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As a global, family-owned business, Mars is transforming, innovating, and evolving to make a positive impact on the world.  Across our diverse and expanding portfolio of quality snacking, food, and pet care products and services, we employ 140,000+ dedicated Associates. With more than $47 billion in annual sales, we produce some of the world’s best-loved brands including Ben’s Original™, CESAR®, Cocoavia®, DOVE®, EXTRA®, KIND®, M&M’s®, SNICKERS®, PEDIGREE®, ROYAL CANIN®, and WHISKAS®. We are creating A Better World for Pets through our global network of pet hospitals and diagnostic services – including AniCura, BANFIELD™, BLUEPEARL™, Linnaeus and VCA™ – using cutting edge technology to develop breakthrough programs in genetic health screening and DNA testing.

For more information about Mars, please visit www.mars.com

View original content:https://www.prnewswire.co.uk/news-releases/1-in-3-pets-are-homeless-according-to-new-global-report–research-shines-a-light-on-challenges-facing-pets-today-302040975.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending